PAK4 and pancreatic neoplasm: Recently, PAK4 has been indicated to enhance the survival and decrease the apoptosis of prostate cancer cells following chemotherapy [31], and to be a predictive marker of gemcitabine sensitivity in pancreatic cancer cell lines [32].